| Aniedi Etukudo Fred Udofa, MD | |
|
3843 Harding Blvd, Baton Rouge, LA 70807-5224 | |
| (225) 953-9315 | |
| (225) 359-9326 |
| Full Name | Aniedi Etukudo Fred Udofa |
|---|---|
| Gender | Female |
| Speciality | Psychiatry |
| Experience | 38 Years |
| Location | 3843 Harding Blvd, Baton Rouge, Louisiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659432193 | NPI | - | NPPES |
| 1572101 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 14261R (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baton Rouge General Medical Center | Baton rouge, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Capital Area Human Services District | 2769450733 | 25 |
News Archive
Researchers from the Indiana University Center for Aging Research and the Regenstrief Institute have performed the first study conducted in the United States under real-world conditions comparing patient adherence and tolerability to a class of drugs known as cholinesterase inhibitors.
The Bill & Melinda Gates Institute for Population and Reproductive Health, based at the Johns Hopkins Bloomberg School of Public Health, is launching The Challenge Initiative, a global urban reproductive health program supported by a three-year, $42 million grant from the Bill & Melinda Gates Foundation.
Transgenomic, Inc. and A. Menarini Diagnostics today announced an exclusive distribution agreement for Transgenomic's SURVEYOR Scan and WAVE MCE (Micro-Capillary Electrophoresis) Mutation Detection system to its network of over 2,000 pathologists throughout Europe.
Patients at a high risk for a second stroke who received intensive medical treatment had fewer strokes and deaths than patients who received a brain stent in addition to the medical treatment, a large nationwide clinical trial has shown. The investigators published the results in today's online first edition of the New England Journal of Medicine.
› Verified 5 days ago
| Entity Name | Capital Area Human Services District |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174681852 PECOS PAC ID: 2769450733 Enrollment ID: O20081118000007 |
News Archive
Researchers from the Indiana University Center for Aging Research and the Regenstrief Institute have performed the first study conducted in the United States under real-world conditions comparing patient adherence and tolerability to a class of drugs known as cholinesterase inhibitors.
The Bill & Melinda Gates Institute for Population and Reproductive Health, based at the Johns Hopkins Bloomberg School of Public Health, is launching The Challenge Initiative, a global urban reproductive health program supported by a three-year, $42 million grant from the Bill & Melinda Gates Foundation.
Transgenomic, Inc. and A. Menarini Diagnostics today announced an exclusive distribution agreement for Transgenomic's SURVEYOR Scan and WAVE MCE (Micro-Capillary Electrophoresis) Mutation Detection system to its network of over 2,000 pathologists throughout Europe.
Patients at a high risk for a second stroke who received intensive medical treatment had fewer strokes and deaths than patients who received a brain stent in addition to the medical treatment, a large nationwide clinical trial has shown. The investigators published the results in today's online first edition of the New England Journal of Medicine.
› Verified 5 days ago
| Entity Name | Capital Area Human Services District |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710047980 PECOS PAC ID: 2769450733 Enrollment ID: O20081118000023 |
News Archive
Researchers from the Indiana University Center for Aging Research and the Regenstrief Institute have performed the first study conducted in the United States under real-world conditions comparing patient adherence and tolerability to a class of drugs known as cholinesterase inhibitors.
The Bill & Melinda Gates Institute for Population and Reproductive Health, based at the Johns Hopkins Bloomberg School of Public Health, is launching The Challenge Initiative, a global urban reproductive health program supported by a three-year, $42 million grant from the Bill & Melinda Gates Foundation.
Transgenomic, Inc. and A. Menarini Diagnostics today announced an exclusive distribution agreement for Transgenomic's SURVEYOR Scan and WAVE MCE (Micro-Capillary Electrophoresis) Mutation Detection system to its network of over 2,000 pathologists throughout Europe.
Patients at a high risk for a second stroke who received intensive medical treatment had fewer strokes and deaths than patients who received a brain stent in addition to the medical treatment, a large nationwide clinical trial has shown. The investigators published the results in today's online first edition of the New England Journal of Medicine.
› Verified 5 days ago
| Entity Name | Capital Area Human Services District |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730104654 PECOS PAC ID: 2769450733 Enrollment ID: O20100114000532 |
News Archive
Researchers from the Indiana University Center for Aging Research and the Regenstrief Institute have performed the first study conducted in the United States under real-world conditions comparing patient adherence and tolerability to a class of drugs known as cholinesterase inhibitors.
The Bill & Melinda Gates Institute for Population and Reproductive Health, based at the Johns Hopkins Bloomberg School of Public Health, is launching The Challenge Initiative, a global urban reproductive health program supported by a three-year, $42 million grant from the Bill & Melinda Gates Foundation.
Transgenomic, Inc. and A. Menarini Diagnostics today announced an exclusive distribution agreement for Transgenomic's SURVEYOR Scan and WAVE MCE (Micro-Capillary Electrophoresis) Mutation Detection system to its network of over 2,000 pathologists throughout Europe.
Patients at a high risk for a second stroke who received intensive medical treatment had fewer strokes and deaths than patients who received a brain stent in addition to the medical treatment, a large nationwide clinical trial has shown. The investigators published the results in today's online first edition of the New England Journal of Medicine.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Aniedi Etukudo Fred Udofa, MD 3843 Harding Blvd, Baton Rouge, LA 70807-5224 Ph: (225) 953-9315 | Aniedi Etukudo Fred Udofa, MD 3843 Harding Blvd, Baton Rouge, LA 70807-5224 Ph: (225) 953-9315 |
News Archive
Researchers from the Indiana University Center for Aging Research and the Regenstrief Institute have performed the first study conducted in the United States under real-world conditions comparing patient adherence and tolerability to a class of drugs known as cholinesterase inhibitors.
The Bill & Melinda Gates Institute for Population and Reproductive Health, based at the Johns Hopkins Bloomberg School of Public Health, is launching The Challenge Initiative, a global urban reproductive health program supported by a three-year, $42 million grant from the Bill & Melinda Gates Foundation.
Transgenomic, Inc. and A. Menarini Diagnostics today announced an exclusive distribution agreement for Transgenomic's SURVEYOR Scan and WAVE MCE (Micro-Capillary Electrophoresis) Mutation Detection system to its network of over 2,000 pathologists throughout Europe.
Patients at a high risk for a second stroke who received intensive medical treatment had fewer strokes and deaths than patients who received a brain stent in addition to the medical treatment, a large nationwide clinical trial has shown. The investigators published the results in today's online first edition of the New England Journal of Medicine.
› Verified 5 days ago
Dr. Donna Brian Fargason, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 9311a Bluebonnet Blvd, Baton Rouge, LA 70810 Phone: 225-769-5551 Fax: 225-769-5583 | |
Kishore M Gadde, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 6400 Perkins Rd, Baton Rouge, LA 70808 Phone: 225-763-2552 | |
Joseph Anthony Grizzaffi Jr., M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 5131 Odonovan Dr, Ste 300, Baton Rouge, LA 70808 Phone: 225-374-0400 Fax: 225-374-0430 | |
Abdul Baset Khan, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 9001 Summa Ave, Baton Rouge, LA 70809 Phone: 225-761-5200 Fax: 225-761-5654 | |
Gerard Dynes, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 7373 Perkins Rd, Baton Rouge, LA 70808 Phone: 225-769-4044 | |
Dr. Kari Akili Jones, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 7521 Kings Hill Ave, Baton Rouge, LA 70810 Phone: 225-267-7141 | |
Dr. Ashok Reddy Polu, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 5000 Hennessy Blvd, Baton Rouge, LA 70808 Phone: 225-765-6565 |